Disease
|
Drug/Important Bio-Agent (IBA)
6 | AntigensIBA
09/2011
-
03/2007 |
2 | fialuridineIBA
10/2008
-
03/2007 |
2 | RadiopharmaceuticalsIBA
10/2008
-
05/2008 |
2 | Bortezomib (Velcade)FDA Link
10/2008
-
03/2007 |
2 | Thymidine KinaseIBA
10/2008
-
03/2007 |
1 | Chemokine ReceptorsIBA
06/2011 |
1 | N-(1,4,8,11- tetraazacyclotetradecanyl- 1,4- phenylenebis(methylene))- 2- (aminomethyl)- pyridineIBA
06/2011 |
1 | pyridineIBA
06/2011 |
1 | Peptides (Polypeptides)IBA
07/2010 |
1 | Gallium-68IBA
07/2010 |
1 | Radioisotopes (Radionuclides)IBA
07/2010 |
1 | iodouracilIBA
10/2008 |
1 | EnzymesIBA
10/2008 |
1 | Cysteine (L-Cysteine)FDA Link
05/2008 |
1 | N- (N- ((S)- 1,3- Dicarboxypropyl)carbamoyl)- 4- (18F)fluorobenzyl- L- cysteineIBA
05/2008 |
1 | IodineIBA
03/2007 |
1 | Anti-Idiotypic AntibodiesIBA
03/2007 |
1 | 1-((1,2,3,4)-2-fluoro-3-hydroxy-4-( hydroxymethyl)cyclopentyl)- 5- iodo- 2,4(1H,3H)- pyrimidinedioneIBA
03/2007 |
1 | Claudin-4IBA
03/2007 |
1 | LuciferasesIBA
03/2007 |
|
Therapy/Procedure
|